Akorn, Inc. manufactures and markets a range of diagnostic and therapeutic ophthalmic pharmaceuticals, as well as niche hospital drugs and injectable pharmaceuticals. In addition, the Company has marketed and distributed vaccines purchased from outside sources. The Company operates in three segments: ophthalmic; hospital drugs and injectables, and contract services. Its customers include physicians, optometrists, hospitals, wholesalers, group purchasing organizations, retail pharmacy chains and other pharmaceutical companies. The Company operates pharmaceutical manufacturing facilities in Decatur, Illinois and Somerset, New Jersey. The Decatur, Illinois facilities operate as part of the Company, while the Somerset, New Jersey facility operates as Akorn (New Jersey), Inc., a wholly owned subsidiary of the Company.